PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Collagen clue reveals new drug target for untreatable form of lung cancer

2013-08-30
(Press-News.org) Collagen, the stuff of ligaments and skin, and the most abundant protein in the human body, has an extraordinary role in triggering chemical signals that help protect the body from cancer, a new study reveals.

Scientists at The Institute of Cancer Research, London, have uncovered a series of chemical signals sent out by collagen that appear to protect against cancer's growth.

Boosting those signals could act as an effective treatment for cancers that grow in the presence of collagen, including squamous cell lung cancer, for which no targeted treatments currently exist.

And the findings suggest that switching off these chemical signals, as some treatments for leukaemia do, is likely to be counter-productive in cancers where interaction with collagen plays an important role.

The study was funded by The Institute of Cancer Research (ICR), the Wellcome Trust and the Biotechnology and Biological Sciences Research Council (BBSRC).

The ICR team explored the role of signals triggered by collagen in human embryonic kidney cells, a type of cell often used in studies of this type. They analysed the role of a molecule called DDR2, which relays signals from collagen as a means of maintaining tissue structure and function, and is mutated in some forms of squamous cell lung cancer.

They treated cells with collagen, and found that DDR2 responded by activating a second protein called SHP-2, in a process that appears to be important in protecting against the growth of some cancers.

But a specific mutant form of DDR2 present in some squamous cell lung cancers seemed unable to signal through SHP-2, suggesting the loss of function had left the tissue vulnerable to cancer growth.

That finding offers an exciting opportunity to design the first targeted treatments for squamous cell lung cancer, perhaps by mimicking the action of SHP-2 to re-erect the normal controls against cancer's growth in the presence of collagen.

Dr Paul Huang, Team Leader in Protein Networks at The Institute of Cancer Research, said: "We knew collagen was capable of slowing the growth of some cancer types, presumably by maintaining the structure of tissues, but our new study for the first time identifies how this effect occurs in lung cancer.

"We sifted through data on 428 different proteins stimulated by collagen, and isolated just one we think can play a key role in protecting tissues from cancer. Identifying this molecular trigger opens up the prospect of targeted treatments for squamous cell lung cancer.

"Importantly, we also highlighted the duplicitous nature of this important signalling network. Although we know it directs a lot of cellular processes that can contribute to cancer -- such as differentiation, proliferation and motility -- in the presence of collagen, it actually seems to protect against cancer. That means we will need to treat cancers that develop in collagen-rich environments differently to blood cancers such as leukaemia."

Professor Alan Ashworth, Chief Executive of The Institute of Cancer Research, said: "Survival rates for lung cancer remain extremely poor, and one of the ways to improve this is to discover new ways of targeting the disease with drugs. This new study is valuable for two reasons -- it identifies an exciting new potential route for treating lung cancers, and it also shows us why some other approaches are unlikely to work.

"Scientifically, these results are very interesting as they demonstrate how one of the most common proteins in the human body plays a role not only in building the structure of tissues but also in cancer."

###

Notes to editors

Squamous cell cancer accounts for around 25 per cent of all lung cancer cases (Heist, R.S., et al., J Thorac Oncol, 2012. 7(5): p. 924-33).

Some cancer drugs developed to target a different signalling pathway in leukaemia -- called BCR-ABL -- actually block the action of DDR2, but this study shows these are unlikely to be effective against specific DDR2 mutations in squamous cell lung cancer.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes. Scientists and clinicians at The Institute of Cancer Research (ICR) are working every day to make a real impact on cancer patients' lives.

Through its unique partnership with The Royal Marsden Hospital and 'bench-to-bedside' approach, the ICR is able to create and deliver results in a way that other institutions cannot. Together the two organisations are rated in the top four cancer centres globally.

The ICR has an outstanding record of achievement dating back more than 100 years. It provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today it leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

As a college of the University of London, the ICR provides postgraduate higher education of international distinction. It has charitable status and relies on support from partner organisations, charities and the general public. The ICR's mission is to make the discoveries that defeat cancer. For more information visit http://www.icr.ac.uk

About BBSRC

BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond. Funded by Government, and with an annual budget of around £467M (2012-2013), we support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals. For more information about BBSRC, our science and our impact see: http://www.bbsrc.ac.uk.

The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. It supports the brightest minds in biomedical research and the medical humanities. The Trust's breadth of support includes public engagement, education and the application of research to improve health. It is independent of both political and commercial interests. http://www.wellcome.ac.uk

The Biochemical Journal is published on behalf of the Biochemical Society by Portland Press Limited (PPL). PPL, the wholly-owned trading subsidiary of the Biochemical Society, is a leading innovative publisher of journals, books and electronic resources. It prides itself on leading the way in content innovation, open access publishing and the delivery of high quality molecular and cellular biosciences research. PPL aims to serve both the scientific community and the aims of the Society in its pursuit of excellence and scientific progression. Profits from the trading activities of PPL are covenanted to the Biochemical Society and returned to the scientific community via its activities.


ELSE PRESS RELEASES FROM THIS DATE:

NASA'S Chandra catches our galaxy's giant black hole rejecting food

2013-08-30
Astronomers using NASA's Chandra X-ray Observatory have taken a major step in explaining why material around the giant black hole at the center of the Milky Way Galaxy is extraordinarily faint in X-rays. This discovery holds important implications for understanding black holes. New Chandra images of Sagittarius A* (Sgr A*), which is located about 26,000 light-years from Earth, indicate that less than 1 percent of the gas initially within Sgr A*'s gravitational grasp ever reaches the point of no return, also called the event horizon. Instead, much of the gas is ejected ...

Novel topological crystalline insulator shows mass appeal

2013-08-30
CHESTNUT HILL, MA (Aug. 29, 2013) – Disrupting the symmetrical structure of a solid-state topological crystalline insulator creates mass in previously mass-less electrons and imparts an unexpected level of control in this nascent class of materials, an international team of researchers reports in the current edition of Science Express. The researchers not only confirmed several theoretical predictions about topological crystalline insulators (TCIs), but made a significant experimental leap forward that revealed even more details about the crystal structure and electronic ...

Time for tech transfer law to change? U-M doctor looks at history of Bayh-Dole and says yes

2013-08-30
ANN ARBOR, Mich. — The law that has helped medical discoveries make the leap from university labs to the marketplace for more than 30 years needs revising, in part to ensure the American people benefit from science their tax dollars have paid for, says a University of Michigan Medical School physician and medical historian. In a new commentary in the New England Journal of Medicine, Howard Markel, M.D., Ph.D., director of the U-M Center for the History of Medicine, looks at the fluke-ridden history of how the law known as Bayh-Dole Technology Transfer Act was passed in ...

Virtual surgical planning aids in complex facial reconstructions

2013-08-30
Philadelphia, Pa. (August 29, 2013) – Virtual surgical planning technologies give surgeons a powerful new tool for their most challenging facial reconstruction cases, reports a paper in the September issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). "Use of virtual surgical planning allows for complex maxillofacial reconstruction with multiple simultaneous free flaps to be preformed reliably and successfully," according to the study by Dr. Adam Saad of Louisiana State University Health Sciences ...

Assay shown to be effective in measuring levels of mutant huntingtin protein

2013-08-30
An assay designed to measure normal and abnormal forms of the huntingtin protein – the mutated form of which causes Huntington's disease (HD) – was successful in detecting levels of the mutant protein in a large multicenter study of individuals at risk for the devastating neurological disorder. The report from a team of Massachusetts General Hospital (MGH) investigators – which will appear in the Sept. 24 issue of Neurology and has been released online – also found changes in levels of the mutated protein that might predict when symptoms will appear. "Our validation ...

Study identifies better blood glucose monitor for burn care

2013-08-30
(SACRAMENTO, Calif.) — Glucose monitoring systems with an autocorrect feature that can detect red blood cells (hematocrit), vitamin C and other common interferents in burn patients' blood are better for monitoring care, a pilot study conducted by UC Davis researchers at the School of Medicine and College of Engineering has found. The study was published in the Journal of Burn Care Research. Burn patients are at risk for high blood glucose levels, or hyperglycemia, due to the body's stress response. Intensive insulin therapy, which is commonly used to keep glucose under ...

Alcohol breaks brain connections needed to process social cues

2013-08-30
Alcohol intoxication reduces communication between two areas of the brain that work together to properly interpret and respond to social signals, according to researchers at the University of Illinois at Chicago College of Medicine. Their results were published in the September issue of Psychopharmacology. Previous research has shown that alcohol suppresses activity in the amygdala, the area of the brain responsible for perceiving social cues such as facial expressions. "Because emotional processing involves both the amygdala and areas of the brain located in the prefrontal ...

UCSB study examines heavy metal pollutants in fish at oil platforms and natural sites

2013-08-30
A recent study by UC Santa Barbara scientists analyzed whole-body fish samples taken from oil-and-gas production platforms and natural sites for heavy metal pollutants. The results showed all but four elements were relatively consistent at both types of location. The findings were published in the Bulletin of Marine Science. The research, led by fish expert Milton S. Love, a research biologist with UCSB's Marine Science Institute, entailed collecting a total of 196 fish –– 18 kelp bass (Paralabrax clathratus), 80 kelp rockfish (Sebastes atrovirens), and 98 Pacific sanddab ...

Protein predicts breast cancer prognosis

2013-08-30
Researchers have identified a protein that they believe may help predict breast cancer prognosis, potentially relieving thousands of women at low risk from having to undergo painful, oft-debilitating therapies, while insuring the most successful treatments for those at high risk. The research was published ahead of print in the journal Molecular and Cellular Biology. Using bioinformatics techniques, the authors showed that the levels of expression of some 1,200 genes that are directly controlled by the enzyme, EZH2, correlates with the aggressiveness of breast cancer ...

Hydrogen fuel from sunlight

2013-08-30
In the search for clean, green sustainable energy sources to meet human needs for generations to come, perhaps no technology matches the ultimate potential of artificial photosynthesis. Bionic leaves that could produce energy-dense fuels from nothing more than sunlight, water and atmosphere-warming carbon dioxide, with no byproducts other than oxygen, represent an ideal alternative to fossil fuels but also pose numerous scientific challenges. A major step toward meeting at least one of these challenges has been achieved by researchers with the U.S. Department of Energy ...

LAST 30 PRESS RELEASES:

Exercise as an anti-ageing intervention to avoid detrimental impact of mental fatigue

UMass Amherst Nursing Professor Emerita honored as ‘Living Legend’

New guidelines aim to improve cystic fibrosis screening

Picky eaters by day, buffet by night: Butterfly, moth diets sync to plant aromas

Pennington Biomedical’s Dr. Leanne Redman honored with the E. V. McCollum Award from the American Society for Nutrition

CCNY physicists uncover electronic interactions mediated via spin waves

Researchers’ 3D-printing formula may transform future of foam

Nurture more important than nature for robotic hand

Drug-delivering aptamers target leukemia stem cells for one-two knockout punch

New study finds that over 95% of sponsored influencer posts on Twitter were not disclosed

New sea grant report helps great lakes fish farmers navigate aquaculture regulations

Strain “trick” improves perovskite solar cells’ efficiency

How GPS helps older drivers stay on the roads

Estrogen and progesterone stimulate the body to make opioids

Dancing with the cells – how acoustically levitating a diamond led to a breakthrough in biotech automation

Machine learning helps construct an evolutionary timeline of bacteria

Cellular regulator of mRNA vaccine revealed... offering new therapeutic options

Animal behavioral diversity at risk in the face of declining biodiversity

Finding their way: GPS ignites independence in older adult drivers

Antibiotic resistance among key bacterial species plateaus over time

‘Some insects are declining but what’s happening to the other 99%?’

Powerful new software platform could reshape biomedical research by making data analysis more accessible

Revealing capillaries and cells in living organs with ultrasound

American College of Physicians awards $260,000 in grants to address equity challenges in obesity care

Researchers from MARE ULisboa discover that the European catfish, an invasive species in Portugal, has a prolonged breeding season, enhancing its invasive potential

Rakesh K. Jain, PhD, FAACR, honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research

Solar cells made of moon dust could power future space exploration

Deporting immigrants may further shrink the health care workforce

Border region emergency medical services in migrant emergency care

Resident physician intentions regarding unionization

[Press-News.org] Collagen clue reveals new drug target for untreatable form of lung cancer